Literature DB >> 14731309

A family-based association study of the 5-HT-1Dbeta receptor gene in obsessive-compulsive disorder.

Beatriz Camarena1, Alejandro Aguilar, Cristina Loyzaga, Humberto Nicolini.   

Abstract

Pharmacological studies have shown that sumatriptan, a selective ligand of the serotonin 5-HT-1Dbeta autoreceptor, modifies obsessive-compulsive disorder (OCD) symptoms. The current study analysed the G861C polymorphism of the 5-HT-1Dbeta gene in a sample of 72 trios. Genotyping data were analysed using the Family-Based Association Test (FBAT). We did not replicate the previously reported linkage disequilibrium between the G861 variant and OCD. However, a quantitative trait analysis, assessing severity of OCD symptoms and defined as YBOCS score, confirmed the finding that subjects with a preferential transmission of the G861 variant showed higher YBOCS Obsession scores compared to patients carrying the C861 allele. These preliminary findings may indicate that the 5-HT-1Dbeta receptor gene could be involved in the severity of obsession symptoms in OCD. However, it is important to perform the replication of these findings in larger sample sizes of informative families.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14731309     DOI: 10.1017/S1461145703003869

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  13 in total

1.  Animal Models for OCD Research.

Authors:  Brittany L Chamberlain; Susanne E Ahmari
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 2.  The genetic studies of obsessive-compulsive disorder and its future directions.

Authors:  Se Joo Kim; Chan-Hyung Kim
Journal:  Yonsei Med J       Date:  2006-08-31       Impact factor: 2.759

Review 3.  Using mice to model Obsessive Compulsive Disorder: From genes to circuits.

Authors:  Susanne E Ahmari
Journal:  Neuroscience       Date:  2015-11-10       Impact factor: 3.590

Review 4.  HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory.

Authors:  Antonio Drago; Silvia Alboni; Nicoletta Brunello; Brunello Nicoletta; Diana De Ronchi; Alessandro Serretti
Journal:  Eur J Clin Pharmacol       Date:  2009-10-07       Impact factor: 2.953

Review 5.  Assessing the validity of current mouse genetic models of obsessive-compulsive disorder.

Authors:  Li Wang; Helen B Simpson; Stephanie C Dulawa
Journal:  Behav Pharmacol       Date:  2009-03       Impact factor: 2.293

6.  The Genetics of Obsessive-Compulsive Disorder.

Authors:  Michael H Bloch; Christopher Pittenger
Journal:  Curr Psychiatry Rev       Date:  2010-05-01

Review 7.  DISSECTING OCD CIRCUITS: FROM ANIMAL MODELS TO TARGETED TREATMENTS.

Authors:  Susanne E Ahmari; Darin D Dougherty
Journal:  Depress Anxiety       Date:  2015-05-07       Impact factor: 6.505

Review 8.  The genetics of obsessive-compulsive disorder: a review.

Authors:  David L Pauls
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

9.  Evidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disorders.

Authors:  Alessandro S De Nadai; Eric A Storch; Joseph F McGuire; Adam B Lewin; Tanya K Murphy
Journal:  J Cent Nerv Syst Dis       Date:  2011-06-01

Review 10.  Genetics of anxiety disorders.

Authors:  Paul D Arnold; Gwyneth Zai; Margaret A Richter
Journal:  Curr Psychiatry Rep       Date:  2004-08       Impact factor: 8.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.